Clinical Trial Update: Study of Tocilizumab in Combination With Methotrexate for Treatment of Moderate to Severe Rheumatoid Arthritis Patients [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the combination of tocilizumab with methotrexate for moderate-to-severe rheumatoid arthritis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Actemra (tocilizumab)
• METHOTREXATE (METHOTREXATE)

Snippet

Sponsor: Chugai Pharma Taiwan | Conditions: Rheumatoid Arthritis (RA) | Phase 3 | Status: COMPLETED